International Journal of Ebola, AIDS, HIV and Infectious Diseases and Immunity (IJEAHII)

EA Journals

Assessment of Compliance to Highly Active Anti-Retroviral Therapy (HAART) among Patients in Selected Hospitals in Ibadan, Oyo State

Abstract

The human immunodeficiency virus (HIV) weakens the immune system, leaving individuals increasingly vulnerable to opportunistic infections. This study assessed compliance with highly active antiretroviral therapy (HAART) among patients at selected hospitals in Ibadan, Oyo State. A structured questionnaire was administered, and its reliability was confirmed using a test-retest method, yielding a coefficient of 0.850. Data were analysed using SPSS version 22, employing descriptive statistics and regression analysis to test the study hypotheses. Findings revealed that 63.9% of respondents exhibited high adherence to HAART, reflecting positive treatment outcomes. However, 37.1% reported difficulty in taking their medication at the same time daily, and 44.3% indicated that stigma and discrimination influenced their willingness to adhere to treatment. One-way ANOVA results showed no statistically significant differences in adherence levels based on education (F = .488, p = .691) and age (F = .382, p = .766). The study concluded that age, gender, education level, and duration on HAART influence adherence patterns, highlighting the need for patient-centred interventions. High overall adherence rates were observed, yet challenges related to psychosocial factors persist. It is recommended that the government establish support groups and counselling services to address emotional and social barriers such as stigma and hopelessness. These initiatives could foster a supportive environment where patients can share experiences, receive peer encouragement, and access professional guidance to enhance sustained adherence to HAART.

Keywords: Assessment, Compliance, Patients, anti-retroviral therapy, highly active

cc logo

This work by European American Journals is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License

 

Recent Publications

Email ID: submission@ea-journals.org
Impact Factor: 8.07
Print ISSN: 2397-7779
Online ISSN: 2397-7787
DOI: https://doi.org/10.37745/ijeahii.15

Author Guidelines
Submit Papers
Review Status

 

Scroll to Top

Don't miss any Call For Paper update from EA Journals

Fill up the form below and get notified everytime we call for new submissions for our journals.